PS Ratio: 162.34

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 162.34 is 25% below its estimated 5-year average of 217.67, near the low end of its estimated 5-year range (95.24–830.55).

As of 2026-10-06T20:26:00.104Z. 26.44% below its estimated 12-month average of 220.70.

CRDF PS Ratio Metrics

P/S vs. estimated history

At 162.34, P/S is at an extreme level, where the multiple carries little signal — higher than 37% of readings in its estimated 16-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The P/S ratio for CRDF stock is 162.34.

Is Cardiff Oncology, Inc.'s P/S ratio high or low?

The P/S ratio of 162.34 is 25% below its estimated 5-year average of 217.67, near the low end of its estimated 5-year range (95.24–830.55).

What is the estimated TTM average P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The estimated TTM average P/S ratio for CRDF stock is 220.70.

What is the estimated 3Y average P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The estimated 3Y average P/S ratio for CRDF stock is 219.61.

What is the estimated 5Y average P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The estimated 5Y average P/S ratio for CRDF stock is 217.67.

What is the estimated 10Y average P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The estimated 10Y average P/S ratio for CRDF stock is 167.19.

What is the estimated 15Y average P/S ratio for Cardiff Oncology, Inc. (CRDF)?

The estimated 15Y average P/S ratio for CRDF stock is 232.16.

Showing the most recent 260 of 3,962 data points. The chart above shows the full history.

Related Metrics